Task shifting to non-physician clinicians for integrated management of hypertension and diabetes in rural Cameroon: a programme assessment at two years

Niklaus D Labhardt, Jean-Richard Balo, Mama Ndam, Jean-Jacques Grimm, Engelbert Manga, Niklaus D Labhardt, Jean-Richard Balo, Mama Ndam, Jean-Jacques Grimm, Engelbert Manga

Abstract

Background: The burden of non-communicable chronic diseases, such as hypertension and diabetes, increases in sub-Saharan Africa. However, the majority of the rural population does still not have access to adequate care. The objective of this study is to examine the effectiveness of integrating care for hypertension and type 2 diabetes by task shifting to non-physician clinician (NPC) facilities in eight rural health districts in Cameroon.

Methods: Of the 75 NPC facilities in the area, 69 (87%) received basic equipment and training in hypertension and diabetes care. Effectiveness was assessed after two years on status of equipment, knowledge among trained NPCs, number of newly detected patients, retention of patients under care, treatment cost to patients and changes in blood pressure (BP) and fasting plasma glucose (FPG) among treated patients.

Results: Two years into the programme, of 54 facilities (78%) available for re-assessment, all possessed a functional sphygmomanometer and stethoscope (65% at baseline); 96% stocked antihypertensive drugs (27% at baseline); 70% possessed a functional glucose meter and 72% stocked oral anti-diabetics (15% and 12% at baseline). NPCs' performance on multiple-choice questions of the knowledge-test was significantly improved. During a period of two years, trained NPCs initiated treatment for 796 patients with hypertension and/or diabetes. The retention of treated patients at one year was 18.1%. Hypertensive and diabetic patients paid a median monthly amount of 1.4 and 0.7 Euro respectively for their medication. Among hypertensive patients with ≥ 2 documented visits (n = 493), systolic BP decreased by 22.8 mmHg (95% CI: -20.6 to -24.9; p < 0.0001) and diastolic BP by 12.4 mmHg (-10.9 to -13.9; p < 0.0001). Among diabetic patients (n = 79) FPG decreased by 3.4 mmol/l (-2.3 to -4.5; p < 0.001).

Conclusions: The integration of hypertension and diabetes into primary health care of NPC facilities in rural Cameroon was feasible in terms of equipment and training, accessible in terms of treatment cost and showed promising BP- and FPG-trends. However, low case-detection rates per NPC and a very high attrition among patients enrolled into care, limited the effectiveness of the programme.

Figures

Figure 1
Figure 1
One-year retention of diabetic and hypertensive patients. Attrition among the 349 patients who were recruited at least 15 months before the assessment. Lost to follow-up was defined as no recorded consultation for ≥ 3 months.
Figure 2
Figure 2
Change of blood pressure among hypertensive patients. Changes in systolic and diastolic blood pressure between the visit where treatment was started (usually the second visit) and the last follow-up visit. Dots are displaying mean values, bars the 95% confidence interval. Groups are according to the WHO grade of hypertension at initiation of therapy. Grade 1 n = 82; grade 2 n = 160; grade 3 n = 196). All changes are significant (p < 0.001).
Figure 3
Figure 3
Change of fasting plasma glucose among diabetic patients. Change in fasting plasma glucose levels between the visit where treatment was started (usually the second visit) and the last follow-up visit among diabetic patients. Dots are displaying mean-values, with brackets indicating the 95% confidence interval. The changes in both groups are significant (sample with 7-10.9 mmol/l at the start of the treatment (n = 35), p-value = 0.0151; sample with≥ 11 mmol/l at the start of the treatment (n = 44), p < 0.001).

References

    1. World Health Organization. Preventing Chronic Diseases. A Vital Investment: WHO Global Report. ISBN 92 4 156300 1. World Health Organization. 2005.
    1. Alwan A, MacLean R. A review of non-communicable disease in low- and middle-income countries. International Health. 2009;1:3–9. doi: 10.1016/j.inhe.2009.02.003.
    1. World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk ISBN 978 92 4 154717 8. World Health Organization. 2007.
    1. Miranda JJ, Kinra S, Casas JP, Davey Smith G, Ebrahim S. Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health. 2008;13:1225–1234. doi: 10.1111/j.1365-3156.2008.02116.x.
    1. Gaziano TA, Reddy KS, Paccaud F, Horton S, Chaturvedi V. In: Disease Control Priorities in Developing Countries. 2. Dean T Jamison, Joel G Breman, Anthony R Measham, George Alleyne, Mariam Claeson, David B Evans, Prabhat Jha, Anne Mills, Philip Musgrove, editor. Washington, D.C.: Oxford University Press and The World Bank; 2006. Cardiovascular Disease (Chapter 33) pp. 645–662.
    1. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007;370:2044–2053. doi: 10.1016/S0140-6736(07)61698-5.
    1. Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R, Rodgers A. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet. 2007;370:2054–2062. doi: 10.1016/S0140-6736(07)61699-7.
    1. Mendis S, Lindholm LH, Mancia G, Whitworth J, Alderman M, Lim S, Heagerty T. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens. 2007;25:1578–1582. doi: 10.1097/HJH.0b013e3282861fd3.
    1. Beaglehole R, Epping-Jordan J, Patel V, Chopra M, Ebrahim S, Kidd M, Haines A. Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet. 2008;372:940–949. doi: 10.1016/S0140-6736(08)61404-X.
    1. World Health Organization; HIV/AIDS Programme. Task shifting to tackle health worker shortages. World Health Organization. 2007.
    1. Stilwell B, Wilson A, McCaffery J. Non-physician clinicians in sub-Saharan Africa. Lancet. 2008;371:1578. doi: 10.1016/S0140-6736(08)60687-X.
    1. Callaghan M, Ford N, Schneider H. A systematic review of task shifting for HIV treatment and care in Africa. Hum Resour Health. 2010;8:8. doi: 10.1186/1478-4491-8-8.
    1. Coleman R, Gill G, Wilkinson D. Noncommunicable disease management in resource-poor settings: a primary care model from rural South Africa. Bull World Health Organ. 1998;76:633–640.
    1. Kengne AP, Awah PK, Fezeu LL, Sobngwi E, Mbanya JC. Primary health care for hypertension by nurses in rural and urban sub-Saharan Africa. J Clin Hypertens (Greenwich) 2009;11:564–572. doi: 10.1111/j.1751-7176.2009.00165.x.
    1. Kengne AP, Fezeu L, Sobngwi E, Awah PK, Aspray TJ, Unwin NC, Mbanya JC. Type 2 diabetes management in nurse-led primary healthcare settings in urban and rural Cameroon. Prim Care Diabetes. 2009;3(3):181–8. doi: 10.1016/j.pcd.2009.08.005.
    1. American Diabetes Assosciation ADA. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2009;32:562–567.
    1. World Health Organization WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. World Health Organization. 2006.
    1. IDF Clinical Guidelines Task Force. Global guideline for Type 2 diabetes. Brussels: International Diabetes Federation. 2005.
    1. Whitworth JA. World Health Organization; International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983–1992. doi: 10.1097/00004872-200311000-00002.
    1. Fezeu LK, Assah FK, Balkau B, Mbanya DS, Kengne AP, Awah PK, Mbanya JC. Ten-year changes in central obesity and BMI in rural and urban Cameroon. Obesity (Silver Spring) 2008;16:1144–1147. doi: 10.1038/oby.2008.44.
    1. Addo J, Smeeth L, Leon DA. Hypertension in sub-saharan Africa: a systematic review. Hypertension. 2007;50:1012–1018. doi: 10.1161/HYPERTENSIONAHA.107.093336.
    1. Gill GV, Mbanya JC, Ramaiya KL, Tesfaye S. A sub-Saharan African perspective of diabetes. Diabetologia. 2009;52:8–16. doi: 10.1007/s00125-008-1167-9.
    1. Stuckler D, King L, Robinson H, McKee M. WHO's budgetary allocations and burden of disease: a comparative analysis. Lancet. 2008;372:1563–1569. doi: 10.1016/S0140-6736(08)61656-6.
    1. Njamnshi A, Hiag A, Mbanya JC. From research to policy: the development of a national diabetes programme in Cameroon. Diabetes Voice. 2006;51:18–21.
    1. Kamadjeu RM, Edwards R, Atanga JS, Unwin N, Kiawi EC, Mbanya JC. Prevalence, awareness and management of hypertension in Cameroon: findings of the 2003 Cameroon Burden of Diabetes Baseline Survey. J Hum Hypertens. 2006;20:91–92. doi: 10.1038/sj.jhh.1001936.
    1. International Diabetes Federation IDF. Electronic Atlas for data on diabetes. International Diabetes Federation. (acessed august 11, 2009)
    1. Bovet P, Gervasoni JP, Ross AG, Mkamba M, Mtasiwa DM, Lengeler C, Burnier M, Paccaud F. Assessing the prevalence of hypertension in populations: are we doing it right? J Hypertens. 2003;21:509–517. doi: 10.1097/00004872-200303000-00016.
    1. Mbuba CK, Newton CR. Packages of care for epilepsy in low- and middle-income countries. PLoS Med. 2009;6:e1000162. doi: 10.1371/journal.pmed.1000162.
    1. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4:e298. doi: 10.1371/journal.pmed.0040298.
    1. Bovet P, Gervasoni JP, Mkamba M, Balampama M, Lengeler C, Paccaud F. Low utilization of health care services following screening for hypertension in Dar es Salaam (Tanzania): a prospective population-based study. BMC Public Health. 2008;8:407. doi: 10.1186/1471-2458-8-407.
    1. Katz I, Schneider H, Shezi Z, Mdleleni G, Gerntholtz T, Butler O, Manderson L, Naicker S. Managing type 2 diabetes in Soweto-The South African Chronic Disease Outreach Program experience. Prim Care Diabetes. 2009;3:157–164. doi: 10.1016/j.pcd.2009.06.007.
    1. Awah PK, Unwin N, Phillimore P. Cure or control: complying with biomedical regime of diabetes in Cameroon. BMC Health Services Research. 2008;8:43. doi: 10.1186/1472-6963-8-43.

Source: PubMed

3
Sottoscrivi